Epidemiology and Genetic Diversity of SARS-CoV-2 Lineages Circulating in Africa

There is a dearth of information on COVID-19 disease dynamics in Africa. To fill this gap, we investigated the epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in the continent. We retrieved 5229 complete genomes collected in 33 African countries from the GISAID database. We investigated the circulating diversity, reconstructed the viral evolutionary divergence and history, and studied the case and death trends in the continent. Almost a fifth (144/782, 18.4%) of Pango lineages found worldwide circulated in Africa, with five different lineages dominating over time. Phylogenetic analysis revealed that African viruses cluster more closely with those from Europe. We also identified two motifs that could function as integrin-binding sites and N-glycosylation domains. These results shed light on the epidemiological and evolutionary dynamics of the circulating viral diversity in Africa. They also emphasize the need to expand surveillance efforts in Africa to help inform and implement better public health measures.

Citing Articles

Tracking the genetic diversity of SARS-CoV-2 variants in Nicaragua throughout the COVID-19 pandemic.

Aleman G, Cerpas C, Juarez J, Moreira H, Arguello S, Coloma J Sci Rep. 2025; 15(1):4817.

PMID: 39924561 PMC: 11808107. DOI: 10.1038/s41598-024-84113-9.

Detached epithelial cell plugs from the upper respiratory tract favour distal lung injury in Golden Syrian hamsters (Mesocricetus auratus) when experimentally infected with the A.2 Brazilian SARS-CoV-2 strain.

Pelajo-Machado M, da Silva A, Rodrigues D, Paiva M, Muller R, da Costa L Mem Inst Oswaldo Cruz. 2024; 119:e240100.

PMID: 39442103 PMC: 11493349. DOI: 10.1590/0074-02760240100.

Rural populations facilitated early SARS-CoV-2 evolution and transmission in Missouri, USA.

Tang C, Li T, Haynes T, McElroy J, Ritter D, Hammer R Npj Viruses. 2024; 1.

PMID: 38186942 PMC: 10769004. DOI: 10.1038/s44298-023-00005-1.

Optimizing ancestral trait reconstruction of large HIV Subtype C datasets through multiple-trait subsampling.

Li X, Trovao N, Wertheim J, Baele G, de Bernardi Schneider A Virus Evol. 2023; 9(2):vead069.

PMID: 38046219 PMC: 10691791. DOI: 10.1093/ve/vead069.

Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron.

Schroder S, Richter A, Veith T, Emanuel J, Gudermann L, Friedmann K Virol J. 2023; 20(1):257.

PMID: 37940989 PMC: 10633978. DOI: 10.1186/s12985-023-02154-4.

References

Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P . In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020; 71(15):732-739. PMC: 7108130. DOI: 10.1093/cid/ciaa237. View

Pastick K, Okafor E, Wang F, Lofgren S, Skipper C, Nicol M . Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19). Open Forum Infect Dis. 2020; 7(4):ofaa130. PMC: 7184359. DOI: 10.1093/ofid/ofaa130. View

Wan Y, Shang J, Graham R, Baric R, Li F . Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020; 94(7). PMC: 7081895. DOI: 10.1128/JVI.00127-20. View

OToole A, Scher E, Underwood A, Jackson B, Hill V, McCrone J . Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 2021; 7(2):veab064. PMC: 8344591. DOI: 10.1093/ve/veab064. View

Reily C, Stewart T, Renfrow M, Novak J . Glycosylation in health and disease. Nat Rev Nephrol. 2019; 15(6):346-366. PMC: 6590709. DOI: 10.1038/s41581-019-0129-4. View

Galban S, Duckett C . XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 2009; 17(1):54-60. PMC: 2957808. DOI: 10.1038/cdd.2009.81. View

Beddingfield B, Iwanaga N, Chapagain P, Zheng W, Roy C, Hu T . The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection. JACC Basic Transl Sci. 2020; 6(1):1-8. PMC: 7566794. DOI: 10.1016/j.jacbts.2020.10.003. View

Grant O, Montgomery D, Ito K, Woods R . Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition. Sci Rep. 2020; 10(1):14991. PMC: 7490396. DOI: 10.1038/s41598-020-71748-7. View

Tamura K, Nei M, Kumar S . Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci U S A. 2004; 101(30):11030-5. PMC: 491989. DOI: 10.1073/pnas.0404206101. View

10.

Toyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K . SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. J Hum Genet. 2020; 65(12):1075-1082. PMC: 7375454. DOI: 10.1038/s10038-020-0808-9. View

11.

Frith M, Saunders N, Kobe B, Bailey T . Discovering sequence motifs with arbitrary insertions and deletions. PLoS Comput Biol. 2008; 4(4):e1000071. PMC: 2323616. DOI: 10.1371/journal.pcbi.1000071. View

12.

Kumar S, Stecher G, Li M, Knyaz C, Tamura K . MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol Biol Evol. 2018; 35(6):1547-1549. PMC: 5967553. DOI: 10.1093/molbev/msy096. View

13.

Makowski L, Olson-Sidford W, W-Weisel J . Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein. Viruses. 2021; 13(2). PMC: 7909284. DOI: 10.3390/v13020146. View

14.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

15.

Plante J, Liu Y, Liu J, Xia H, Johnson B, Lokugamage K . Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2020; 592(7852):116-121. PMC: 8158177. DOI: 10.1038/s41586-020-2895-3. View

16.

Alanagreh L, Alzoughool F, Atoum M . The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms. Pathogens. 2020; 9(5). PMC: 7280997. DOI: 10.3390/pathogens9050331. View

17.

Aiewsakun P, Nilplub P, Wongtrakoongate P, Hongeng S, Thitithanyanont A . SARS-CoV-2 genetic variations associated with COVID-19 pathogenicity. Microb Genom. 2021; 7(12). PMC: 8767342. DOI: 10.1099/mgen.0.000734. View

18.

Wang C, Horby P, Hayden F, Gao G . A novel coronavirus outbreak of global health concern. Lancet. 2020; 395(10223):470-473. PMC: 7135038. DOI: 10.1016/S0140-6736(20)30185-9. View

19.

Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H . The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020; 7(1):11. PMC: 7068984. DOI: 10.1186/s40779-020-00240-0. View

20.

Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View